Acasă › Boala Crohn › Michigan
Studii clinice pentru Boala Crohn în Michigan
20 studii pentru Boala Crohn caută participanți în Michigan.
Orașe în Michigan
Text oficial al studiului (în engleză)
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- St. Joseph Mercy Hospital - Huron Gastroenterology Associates ( Site 0287), Ypsilanti
În curs de recrutareFaza 3
Toate vârstele · Toate sexele · Actualizat 2 oct. 2026 · NCT06651281A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- University of Michigan ( Site 5060), Ann Arbor
- Clinical Research Institute of Michigan, LLC ( Site 5002), Clinton Township
În curs de recrutareFaza 3
Vârste de la 16 la 80 · Toate sexele · Actualizat 2 oct. 2026 · NCT06430801Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- West Michigan Clinical Research Center /ID# 280480, Wyoming
În curs de recrutareFaza 2
Vârste de la 18 la 75 · Toate sexele · Actualizat 2 oct. 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastroenterology Associates of Western Michigan, P.L.C., Wyoming
- Huron Gastro, Ypsilanti
În curs de recrutareFaza 4
Vârste de la 18 la 80 · Toate sexele · Actualizat 30 sept. 2026 · NCT06581328Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Henry Ford Medical Center - Columbus /ID# 266503, Novi
În curs de recrutareFaza 2
Vârste de la 18 la 75 · Toate sexele · Actualizat 25 sept. 2026 · NCT06548542A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Michigan Center of Medical Research, Farmington Hills
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 25 sept. 2026 · NCT07499232An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Henry Ford Medical Center - Columbus-Site Number: 8400118, Novi
- Gastroenterology Associates of Western Michigan-Site Number: 8400060, Wyoming
În curs de recrutareFaza 3
Vârste de la 16 la 80 · Toate sexele · Actualizat 23 sept. 2026 · NCT07184931A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Gastroenterology Associates of Western Michigan, PLC d.b.a. West Michigan Clinical Research Center, Wyoming
În curs de recrutareFaza 2
Vârste de la 18 la 80 · Toate sexele · Actualizat 22 sept. 2026 · NCT07483073A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
- Gastroenterology Associates of Western Michigan, PLC d.b.a. West Michigan Clinical Research Center, Wyoming
În curs de recrutareFaza 2
Vârste de la 18 la 80 · Toate sexele · Actualizat 22 sept. 2026 · NCT07483099A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- Huron Gastroenterology Associates, P.C., Ypsilanti
În curs de recrutareFaza 4
Vârste de la 18 la 70 · Toate sexele · Actualizat 9 sept. 2026 · NCT06045754A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- Michigan Center of Medical Research, Farmington Hills
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 28 aug. 2026 · NCT07577843A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- Children's Hospital of Michigan, Detroit
În curs de recrutareFaza 3
Vârste de la 2 la 17 · Toate sexele · Actualizat 3 aug. 2026 · NCT06100289Developing a Self-Management Intervention to Improve Health Outcomes for Patients With Inflammatory Bowel Disease
- University of Micigan, Ann Arbor
În curs de recrutare
Vârste de 18 ani și peste · Toate sexele · Actualizat 23 iul. 2026 · NCT07456566A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Childrens Hospital of Michigan, Detroit
În curs de recrutareFaza 3
Vârste de la 2 la 17 · Toate sexele · Actualizat 22 iun. 2026 · NCT06405087Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
- University of Michigan, Ann Arbor
În curs de recrutareFaza 4
Vârste de la 6 la 17 · Toate sexele · Actualizat 27 mai 2026 · NCT05781152Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- Henry Ford Columbus Center, Detroit
În curs de recrutareFaza 2
Vârste de la 18 la 75 · Toate sexele · Actualizat 27 apr. 2026 · NCT06456593A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
- Investigational Site Number: 8400008, Wyoming
În curs de recrutareFaza 2
Vârste de la 18 la 75 · Toate sexele · Actualizat 27 mar. 2026 · NCT06958536A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Ypsilanti
În curs de recrutareFaza 2
Vârste de la 18 la 80 · Toate sexele · Actualizat 12 mar. 2026 · NCT07113522A Pilot Study Examining Low Sulfur Diet as Treatment for Persistent Symptoms in Quiescent Crohn's Disease
- University of Michigan, Ann Arbor
În curs de recrutare
Vârste de 18 ani și peste · Toate sexele · Actualizat 15 ian. 2026 · NCT05849012Treatment of Moderate to Severe Refractory Crohn's Disease
- University of Michigan, Ann Arbor
În curs de recrutareFaza 1/2
Vârste de la 18 la 65 · Toate sexele · Actualizat 10 dec. 2025 · NCT06721962Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.